Cutaneous leishmaniases Clinical Trials
Conditions / Cutaneous leishmaniases
Delta Trials records 10 clinical trials for Cutaneous leishmaniases in its publicly accessible dataset. From the full dataset, 1 actively seeking eligible participants and 6 trials have reached completion. This research is conducted across 14 study locations around the world. An additional 3 trials are active but not currently open for enrollment. Since 2020, 3 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
10
Total Trials
1
Recruiting
6
Completed
3
Other Active
3
Terminated since 2020
14
Study Locations
Browse by location (14 total)
- Gonder, Ethiopia 3 trialsAll trials in Gonder, Ethiopia
- Boru, Ethiopia 1 trialAll trials in Boru, Ethiopia
- Panama City, Panama 1 trialAll trials in Panama City, Panama
- Lima, Peru 1 trialAll trials in Lima, Peru
- Antwerp, Belgium 1 trialAll trials in Antwerp, Belgium
- Freiburg Im Breisgau, Germany 1 trialAll trials in Freiburg Im Breisgau, Germany
- Salvador, Brazil 1 trialAll trials in Salvador, Brazil
- Nottingham, United Kingdom 1 trialAll trials in Nottingham, United Kingdom
- Santa Cruz de la Sierra, Bolivia 1 trialAll trials in Santa Cruz de la Sierra, Bolivia
- York, United Kingdom 1 trialAll trials in York, United Kingdom
- Belo Horizonte, Brazil 1 trialAll trials in Belo Horizonte, Brazil
- Quetta, Pakistan 1 trialAll trials in Quetta, Pakistan
- Addis Ababa, Ethiopia 1 trialAll trials in Addis Ababa, Ethiopia
- Cuiabá, Brazil 1 trialAll trials in Cuiabá, Brazil
- Cuiabá, Brazil 1 trialAll trials in Cuiabá, Brazil